Geode Capital Management’s PharmaCyte Biotech PMCB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $139K | Sell |
126,603
-12,332
| -9% | -$13.6K | ﹤0.01% | 3978 |
|
|
2025
Q1 | $174K | Sell |
138,935
-25,801
| -16% | -$32.3K | ﹤0.01% | 3889 |
|
|
2024
Q4 | $255K | Sell |
164,736
-3,464
| -2% | -$5.37K | ﹤0.01% | 3817 |
|
|
2024
Q3 | $321K | Sell |
168,200
-8,405
| -5% | -$16.1K | ﹤0.01% | 3742 |
|
|
2024
Q2 | $346K | Sell |
176,605
-23,676
| -12% | -$46.4K | ﹤0.01% | 3710 |
|
|
2024
Q1 | $475K | Sell |
200,281
-15,356
| -7% | -$36.4K | ﹤0.01% | 3638 |
|
|
2023
Q4 | $466K | Sell |
215,637
-3,473
| -2% | -$7.5K | ﹤0.01% | 3642 |
|
|
2023
Q3 | $460K | Buy |
219,110
+36
| +0% | +$76 | ﹤0.01% | 3630 |
|
|
2023
Q2 | $627K | Buy |
219,074
+43,810
| +25% | +$125K | ﹤0.01% | 3557 |
|
|
2023
Q1 | $510K | Hold |
175,264
| – | – | ﹤0.01% | 3641 |
|
|
2022
Q4 | $511K | Sell |
175,264
-343
| -0.2% | -$1K | ﹤0.01% | 3650 |
|
|
2022
Q3 | $421K | Hold |
175,607
| – | – | ﹤0.01% | 3811 |
|
|
2022
Q2 | $396K | Buy |
175,607
+4,084
| +2% | +$9.21K | ﹤0.01% | 3891 |
|
|
2022
Q1 | $394K | Buy |
171,523
+87,948
| +105% | +$202K | ﹤0.01% | 4062 |
|
|
2021
Q4 | $208K | Buy |
83,575
+36,965
| +79% | +$92K | ﹤0.01% | 4457 |
|
|
2021
Q3 | $147K | Buy |
+46,610
| New | +$147K | ﹤0.01% | 4557 |
|